Monday, December 1, 2008 - 10:15PM EST

Review Articles

11. Emerging drugs for targeted therapy of bladder cancer.

Author
Agarwal PK; Black PC; McConkey DJ; Dinney CP;
Institution
Department of Urology, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.
Journal
Expert Opin Emerg Drugs. 2007 Sep;12(3):435-48.
Abstract URL
Click here to view abstract

12. Intravesical pharmacotherapy for non-muscle-invasive bladder cancer: a critical analysis of currently available drugs, treatment schedules, and long-term results.

Author
Witjes JA; Hendricksen K;
Institution
Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. F.Witjes@uro.umcn.nl
Journal
Eur Urol. 2008 Jan;53(1):45-52. Epub 2007 Aug 20.
Abstract URL
Click here to view abstract

13. Management of BCG failures in superficial bladder cancer: a review.

Author
Witjes JA;
Institution
Department of Urology, University Medical Centre St. Radboud, PO Box 9101, 6500 HB Nijmegen, The Netherlands. F.Witjes@uro.umcn.nl
Journal
Eur Urol. 2006 May;49(5):790-7. Epub 2006 Jan 24.
Abstract URL
Click here to view abstract

14. The schedule and duration of intravesical chemotherapy in patients with non-muscle-invasive bladder cancer: a systematic review of the published results of randomized clinical trials.

Author
Sylvester RJ; Oosterlinck W; Witjes JA;
Institution
EORTC Data Center, Brussels, Belgium. richard.sylvester@eortc.be <richard.sylvester@eortc.be>
Journal
Eur Urol. 2008 Apr;53(4):709-19. Epub 2008 Jan 15.
Abstract URL
Click here to view abstract

15. Quality-of-life assessment in patients with bladder cancer.

Author
Wright JL; Porter MP;
Institution
Department of Urology, University of Washington, Seattle, WA 98108, USA.
Journal
Nat Clin Pract Urol. 2007 Mar;4(3):147-54.
Abstract URL
Click here to view abstract

16. Radical cystectomy with an extended pelvic lymphadenectomy: rationale and results.

Author
Mills RD; Fleischmann A; Studer UE;
Institution
The Norfolk and Norwich University Hospital, Colney Lane, Norwich NR4 7UY, UK.
Journal
Surg Oncol Clin N Am. 2007 Jan;16(1):233-45.
Abstract URL
Click here to view abstract

17. Nonurothelial cancer of the bladder.

Author
Abol-Enein H; Kava BR; Carmack AJ;
Institution
Department of Urology, University of Mansoura, Urology and Nephrology Center, Egypt. hassan_abolenein@hotmail.com
Journal
Urology. 2007 Jan;69(1 Suppl):93-104.
Abstract URL
Click here to view abstract

18. Complications of intravesical therapy for urothelial cancer of the bladder.

Author
Koya MP; Simon MA; Soloway MS;
Institution
Department of Urology, University of Miami School of Medicine, Miami, Florida 33136, USA.
Journal
J Urol. 2006 Jun;175(6):2004-10.
Abstract URL
Click here to view abstract

19. Clinical outcome after cystectomy in patients with lymph node-positive bladder cancer.

Author
Nagele U; Anastasiadis AG; Merseburger AS; Sievert KD; Stenzl A; Kuczyk M;
Institution
Department of Urology, University of Tuebingen, Hoppe-Seyler-Str. 3, Tuebingen 72076, Germany. udo.nagele@med.uni-tuebingen.de
Journal
Expert Rev Anticancer Ther. 2006 Jun;6(6):871-6.
Abstract URL
Click here to view abstract

20. Chemoprevention for bladder cancer.

Author
Busby JE; Kamat AM;
Institution
Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-4009, USA.
Journal
J Urol. 2006 Nov;176(5):1914-20.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5 6